RGT argent biopharma limited

6.25%

8.5¢

It's getting interesting, page-9

First 9 Last

Share
Profile

Follow
debal

361 Posts.

09/03/17

07:34

Post #: 23203880
Share

Originally posted by tronbirk ↑

I will for you Debal.

Both the article I posted and the journalist Sea blue quoted have both said that MGC don't have a license to produce MM.
Even the article he quoted from the AFR is bullshit. Yes, they got a license to produce cannabis in Slovenia, but it's smoke and mirrors. The license was for Fedora 17. I posted this info in my first post. They got a license to grow an industrial hemp which anyone can get, it's not difficult to get at all.

So Sea blue's posts are pure ignorance and have no value at all.

I also don't see my post as down ramping, I've clearly stated that there might be something very big cooking. The influence of a company with a €40 million mkt cap and x amount of employees in such a small country is nothing to scoff at. Also doing clinical trials may be a very very smart way of currying favor and getting around certain regulations whereby MM (I think) could possibly be grown for clinical research purposes.

Someone will no doubt say the strain of hemp/MM MGC has is below they .2% limit. Once again - Fedora 17.

For now though medical marijuana IS NOT permitted to be grown in Slovenia and NO licenses have been given out yet. Also it's not allowed to prooduce resin from marijuane. The laws are complex here and I won't go into explaining them but The laws are currently under review and most likely will be changed.

I hope this is clear as I really can't be bothered going through this again.

Good luck MGC - in all sincerity.

Expand

Thank you, much as I'd interpreted and don't believe either of you are ramping.

I think others who stumble upon this thread will also appreciate the clarification as much can be lost in translation at times.

Appreciate your efforts - don't stop (please)

Last edited by debal: 09/03/17

MXC Price at posting: 6.8¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

LDX

Lumos Diagnostics surges 140% on major US contract deal

IMU

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

LIS

Li-S Energy the latest microcap to pivot to US defence market

NOX

Noxopharm gets HERACLES autoimmune trials started with first human doses

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 8.5¢		Change 0.005(6.25%)		Mkt cap ! $6.496M

Open	High	Low	Value	Volume
7.9¢	9.0¢	7.9¢	$4.744K	56.33K

Buyers (Bids)

No.	Vol.	Price($)
1	20000	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.5¢	57648	1

View Market Depth

No.	Vol.	Price($)
1	20000	0.080
1	24480	0.079
1	25000	0.078
1	56000	0.077
2	10632	0.076

Price($)	Vol.	No.
0.085	57648	1
0.094	3000	1
0.095	74	1
0.100	20000	1
0.120	8340	1

Last trade - 13.32pm 16/07/2025 (20 minute delay)

RGT (ASX) Chart

It's getting interesting, page-9

Lumos Diagnostics surges 140% on major US contract deal

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Li-S Energy the latest microcap to pivot to US defence market

Noxopharm gets HERACLES autoimmune trials started with first human doses

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

It's getting interesting, page-9

Top Stories

Lumos Diagnostics surges 140% on major US contract deal

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Li-S Energy the latest microcap to pivot to US defence market

Noxopharm gets HERACLES autoimmune trials started with first human doses

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News